Federal Register / Vol. 72, No. 53 / Tuesday, March 20, 2007 / Notices 13117 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. 2006N–0187] 

Agency Information Collection 

Activities; Submission for Office of 

Management and Budget Review; 

Comment Request; Survey of Health 

Care Professionals on the Food Safety 

and Nutrition Information That They 

Provide to Pregnant Women 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing 

that a proposed collection of 

information has been submitted to the 

Office of Management and Budget 

(OMB) for review and clearance under 

the Paperwork Reduction Act of 1995. 

DATES: Fax written comments on the 

collection of information by April 19, 

2007. 

ADDRESSES: To ensure that comments on 

the information collection are received, 

OMB recommends that written 

comments be faxed to the Office of 

Information and Regulatory Affairs, 

OMB, Attn: FDA Desk Officer, FAX: 

202–395–6974. 

FOR FURTHER INFORMATION CONTACT: 

Jonna Capezzuto, Office of the Chief 

Information Officer (HFA–250), Food 

and Drug Administration, 5600 Fishers 

Lane, Rockville, MD 20857, 301–827–

4659. 

SUPPLEMENTARY INFORMATION: In 

compliance with 44 U.S.C. 3507, FDA 

has submitted the following proposed 

collection of information to OMB for 

review and clearance. 

Survey of Health Care Professionals on 

the Food Safety and Nutrition 

Information That They Provide to 

Pregnant Women 

Under section 903(b)(2) of the Federal 

Food, Drug, and Cosmetic Act (21 U.S.C. 

393(b)(2)), FDA is authorized to conduct 

research relating to foods and to 

conduct educational and public 

information programs relating to the 

safety of the nation’s food supply. FDA 

is planning to conduct a survey of 

health care professionals to determine 

what information, advice, and 

recommendations they are offering to 

pregnant women about the following 

topics: (1) Methyl mercury and seafood 

consumption, (2) Listeriosis prevention, 

(3) weight control and nutrition, (4) 

dietary supplement usage, (5) food 

allergies, (6) Toxoplasmosis prevention, 

and (7) infant feeding practices. FDA is 

interested in obtaining this data since 

FDA has recently issued advice for 

pregnant women about food safety risks 

and diet risks such as mercury in 

seafood, Listeriosis, and Toxoplamosis. 

(‘‘Food Safety for Moms-to-Be,’’ 2005 

and ‘‘What You Need to Know about 

Mercury in Fish and Shellfish,’’ 2004). 

Data from this survey will be used to 

evaluate whether health care 

professionals are aware of this advice 

and if they are educating their patients 

about information in the FDA 

advisories. 

FDA will also use this survey to get 

a better understanding of what resources 

health care professionals use to stay 

abreast of current practices for caring for 

pregnant women. This will help FDA 

provide timely recommendations to 

health care professionals that will reach 

the largest audience. 

A sample of 400 obstetrician/ 

gynecologists, 200 nurse practitioners, 

200 nurse midwives, 200 physician 

assistants, and 200 dietitians from the 

Special Supplemental Nutrition 

Program for Women, Infants, and 

Children (WIC) will be included in this 

survey. The sample of nurse 

practitioners, nurse midwives, and 

physician assistants will be drawn from 

those specializing in obstetrics. The 

samples will be randomly selected from 

lists obtained from national 

associations. The survey will be 

conducted using a mailed questionnaire. 

Cognitive interviews and a pretest will 

be conducted prior to fielding the 

survey. 

In the Federal Register of June 2, 2006 

(71 FR 32095), FDA published a 60-day 

notice requesting public comment on 

the information collection provisions. 

FDA received one comment responsive 

to the comment request. 

(Comment) The comment suggests 

that FDA should expand the respondent 

universe of the survey to include all 

categories of health care providers that 

care for pregnant women. 

(Response) FDA agrees that the survey 

universe should include samples drawn 

from all categories of health care 

providers that provide care for pregnant 

women. The current sampling plan calls 

for samples of 400 obstetrician/ 

gynecologists, 200 nurse practitioners, 

200 certified nurse midwives, 200 

physician assistants, and 200 WIC 

nutrition educators. 

TABLE 1.—ESTIMATED ANNUAL REPORTING BURDEN1

No. of Respondents Annual Frequency 

Per Response 

Total Annual 

Responses 

Hours Per 

Response Total Hours 

1,200—Survey 1 1,200 .167 200 .4 

75—Pretest 1 75 .167 12 .5 

16—Cognitive Interview 1 16 .75 12 

Total 1 1,291 224 .9 

1There are no capital costs or operating and maintenance costs associated with this collection of information. 


pwalker on PROD1PC71 with NOTICES
13118 Federal Register / Vol. 72, No. 53 / Tuesday, March 20, 2007 / Notices 

The burden estimate is based on 

FDA’s experience with previous 

surveys. 

Dated: March 15, 2007. 

Jeffrey Shuren, 

Assistant Commissioner for Policy. 

[FR Doc. E7–5046 Filed 3–19–07; 8:45 am] 

BILLING CODE 4160–01–S 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Neurological 

Disorders and Stroke; Notice of Closed 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National 

Institute of Neurological Disorders and 

Stroke Special Emphasis Panel, Survival 

Skills and Ethics. 

Date: March 28, 2007. 

Time: 11 a.m. to 12 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852 

(Telephone Conference Call). 

Contact Person: Phillip F. Wiethorn, 

Scientific Review Administrator, DHHS/ 

NIH/NINDS/DER/SRB, 6001 Executive 

Boulevard, MSC 9529, Neuroscience 

Center, Room 3203, Bethesda, MD 

20892–9529, (301) 496–5388, 

wiethorp@ninds.nih.gov. 

This notice is being published less 

than 15 days prior to the meeting due 

to the timing limitations imposed by the 

review and funding cycle. 

Name of Committee: National 

Institute of Neurological Disorders and 

Stroke Special Emphasis Panel, 

Migraine. 

Date: April 10, 2007. 

Time: 10 a.m. to 2 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852 

(Telephone Conference Call). 

Contact Person: Katherine Woodbury, 

PhD, Scientific Review Administrator, 

Scientific Review Branch, NINDS/NIH/ 

DHHS, Neuroscience Center, 6001 

Executive Blvd., Suite 3208, MSC 9529, 

Bethesda, MD 20892–9529, (301) 496–

5980, kw47o@nih.gov. 

This notice is being published less 

than 15 days prior to the meeting due 

to the timing limitations imposed by the 

review and funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.853, Clinical Research 

Related to Neurological Disorders; 93.854, 

Biological Basis Research in the 

Neurosciences, National Institutes of Health, 

HHS.) 

Dated: March 14, 2007. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–1345 Filed 3–19–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Child Health and 

Human Development; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Child Health and Human Development 

Special Emphasis Panel, DNA Looping. 

Date: April 18, 2007. 

Time: 3:30 p.m. to 4:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6100 

Executive Boulevard, 5B01, Rockville, MD 

20852 (Telephone Conference Call). 

Contact Person: Norman Chang, PhD, 

Scientific Review Administrator, Division of 

Scientific Review, National Institute of Child 

Health and Human Development, NIH, 6100 

Executive Blvd., Room 5B01, Bethesda, MD 

20892. (301) 496–1485. 

changn@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.864, Population Research; 

93.865, Research for Mothers and Children; 

93.929, Center for Medical Rehabilitation 

Research; 93.209, Contraception and 

Infertility Loan Repayment Program, National 

Institutes of Health, HHS.) 

Dated: March 13, 2007. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–1348 Filed 3–19–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Child Health and 

Human Development; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in section 

552b(c)(6), Title 5 U.S.C., as amended. 

The grant applications and the 

discussions could disclose confidential 

trade secrets or commercial property 

such as patentable material, and 

personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Child Health and Human Development 

Special Emphasis Panel, Developmental 

Infrastructure For Population Research. 

Date: April 12–13, 2007. 

Time: 9 a.m. to 7 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hotel Washington, 515 15th Street, 

NW., Council Room, Washington, DC 20004. 

Contact Person: Marita R. Hopmann, PhD, 

Scientific Review Administrator, Division of 

Scientific Review, National Institute of Child 

Health, and Human Development, 6100 

Building, Room 5B01, Bethesda, MD 20892. 

(301) 435–6911. hopmannm@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.864, Population Research; 

93.865, Research for Mothers and Children; 

93.929, Center for Medical Rehabilitation 

Research; 93.209, Contraception and 

Infertility Loan Repayment Program, National 

Institutes of Health, HHS.) 

Dated: March 13, 2007. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–1349 Filed 3–19–07; 8:45 am] 

BILLING CODE 4140–01–M 


pwalker on PROD1PC71 with NOTICES